Emergent Biosolutions
EBS
EBS
162 hedge funds and large institutions have $141M invested in Emergent Biosolutions in 2023 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 47 increasing their positions, 54 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
46% less call options, than puts
Call options by funds: $314K | Put options by funds: $580K
58% less capital invested
Capital invested by funds: $336M → $141M (-$195M)
Holders
162
Holding in Top 10
–
Calls
$314K
Puts
$580K
Top Buyers
| 1 | +$8.11M | |
| 2 | +$4.4M | |
| 3 | +$1.97M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.91M |
| 5 |
Squarepoint
New York
|
+$1.83M |
Top Sellers
| 1 | -$19.3M | |
| 2 | -$5.77M | |
| 3 | -$4.27M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$3.47M |
| 5 |
Man Group
London,
United Kingdom
|
-$3.31M |